Stockreport

Intensity Therapeutics receives 180-day Nasdaq extension to regain compliance [Seeking Alpha]

Intensity Therapeutics, Inc.  (INTS) 
PDF The new deadline is June 1, 2026, following the expiration of the initial compliance period on December 3, 2025. INTS shares up 3.4% premarket on Friday. More on In [Read more]